Could the development of products that produce a constant level of exogenous Reactive Oxygen® be beneficial in preventing and treating polymicrobial wound infections? Discover the potential of this avenue for multi-drug resistant organisms and more in our latest opinion piece.
Browsing: Disease Area > Bacterial
Microbiome metabolites have been discovered to enhance colon injury in human EHEC infections in a human–mouse comparative study, accounting for species-specific differences in infection tolerance.
The latest report from the ECDC and WHO has analysed the 2017 data for the European region, suggesting that despite an overall decline in the number of cases, TB remains a major public health challenge.
Dr. Suvanand Sahu, Deputy Executive Director, at the Stop TB Partnership, reflects on the UNHLM on TB outlining the progress that was made and what more needs to be done.
In line with World Tuberculosis Day 2019, we are hosting a Twitter chat #TalkTB with prominent experts in the field of tuberculosis on Thursday March 21 at 11:00 EDT / 15:00 GMT.
Take a look at this month’s industry headlines including Priority Review for two antibacterial agents from Merck (NJ, USA), a clinical trial for a new malaria drug and the launch of omadacycline in the USA.
New research reveals how Pseudomonas aeruginosa delivers toxins via communication molecules to cause illness.
A new rapid microelectrode device for the earlier diagnosis of sepsis has been developed by researchers at the University of Strathclyde.